跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,162 条关于
“FGF-21”
全部
4,162
临床试验
1,394
药物
572
机构
111
资讯
2,085
去年
e-therapeutics' ETX-312 Shows Promise as Disease-Modifying MASH Treatment in Preclinical Studies
去年
Long-Term Obesity Accelerates Biological Aging in Young Adults, Study Finds
去年
Recent Advances and Therapeutic Applications of FGF-based Drug Development
去年
AAO 2024: 3D-Printed Glasses, ANX007 for Geographic Atrophy, and Cataract Surgery Risks Highlighted
去年
MD Anderson Highlights: Modified NRF2 Activator Reverses Chronic Pain, Canakinumab Shows Promise in MDS Subgroup
去年
Merck's CAPVAXIVE Shows Promise Against Pneumococcal Disease in Adults
去年
FDA Approves Abrysvo for RSV Prevention in Adults 18-59 at Increased Risk
去年
MD Anderson Research Highlights: Modified NRF2 Activator, Canakinumab in MDS, and More
去年
Grifols Receives $21 Million Grant to Identify Parkinson's Disease Biomarkers
去年
FDA Approves Capvaxive, First Adult-Specific 21-Valent Pneumococcal Vaccine
第 1 页,共 209 页
上一页
下一页